The new PET tracer, 18F-SNFT-1, developed through collaborative research at our center and targeting the tau protein, a pathological marker of Alzheimer’s disease, has been featured in a press release by The Society of Nuclear Medicine and Molecular Imaging in the United States.
The new PET tracer 18F-SNFT-1, developed through collaborative research at our center and targeting the tau protein, a pathological marker of Alzheimer’s disease, has been introduced in a press release by The Society of Nuclear Medicine and Molecular Imaging in the United States.
You can find the press release here.
